insights_auto
Por qué ha subido COR 2,99%?
Profundizarchevron_right
COR:NYSE
Cencora
359,03 US$
arrow_upward
+2,99%(+10,42) 1 d
13 nov, 16:00:05 GMT-5 · USD
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de COR...
Abrir
351,12 US$
Alto
359,39 US$
Bajo
350,11 US$
Cap. burs.
15,87 mil M
Vol. medio
1,31 M
Volumen
0,00
Máximo en 52 sem.
377,54 US$
Mínimo en 52 sem.
244,82 US$
Beta
0,58
Acciones en circulación
190,83 M
N.º de empleados
49 mil
Abrir
351,12 US$
Alto
359,39 US$
Bajo
350,11 US$
Cap. burs.
15,87 mil M
Vol. medio
1,31 M
Volumen
0,00
Máximo en 52 sem.
377,54 US$
Mínimo en 52 sem.
244,82 US$
Beta
0,58
Acciones en circulación
190,83 M
N.º de empleados
49 mil
Noticias
De fuentes web y partners de noticias
Investing.com
·
hace 2 días
US FTC sues to block Cencora’s $3.5 billion sale of veterinary unit to Covetrus By Reuters
Perfil
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
Acerca de Cencora